Bellevue Group AG Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$957.2B
Holdings
134
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (134 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —INTERSECT ENT INC | 38,430 | $1.2B | 0.13% | |
| 102 | PODDINSULET CORP | 18,000 | $1.2B | 0.13% | |
| 103 | CAHCARDINAL HEALTH INC | 20,000 | $1.2B | 0.13% | |
| 104 | CLVSEURCLOVIS ONCOLOGY INC | 18,000 | $1.2B | 0.13% | |
| 105 | PRTAPROTHENA CORP PLC | 31,350 | $1.2B | 0.12% | |
| 106 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 19,400 | $1.1B | 0.12% | |
| 107 | —RADIUS HEALTH INC | 33,800 | $1.1B | 0.11% | |
| 108 | PFEPFIZER INC | 29,200 | $1.1B | 0.11% | |
| 109 | ACADACADIA PHARMACEUTICALS INC | 35,050 | $1.1B | 0.11% | |
| 110 | DVAXDYNAVAX TECHNOLOGIES CORP | 55,000 | $1.0B | 0.11% | |
| 111 | OMCLOMNICELL INC | 20,000 | $970.0M | 0.10% | |
| 112 | —HMS HLDGS CORP | 53,500 | $907.0M | 0.09% | |
| 113 | VAREURVARIAN MED SYS INC | 7,000 | $778.0M | 0.08% | |
| 114 | GKOSGLAUKOS CORP | 30,000 | $770.0M | 0.08% | |
| 115 | NVROEURNEVRO CORP | 10,700 | $739.0M | 0.08% | |
| 116 | CLLSCELLECTIS S A | 24,350 | $710.0M | 0.07% | |
| 117 | —COTIVITI HLDGS INC | 21,708 | $699.0M | 0.07% | |
| 118 | —GW PHARMACEUTICALS PLC | 4,950 | $653.0M | 0.07% | |
| 119 | CVSCVS HEALTH CORP | 8,800 | $638.0M | 0.07% | |
| 120 | INOINOVIO PHARMACEUTICALS INC | 140,100 | $579.0M | 0.06% | |
| 121 | —BIOVERATIV INC | 10,200 | $550.0M | 0.06% | |
| 122 | —QUOTIENT LTD | 110,000 | $545.0M | 0.06% | |
| 123 | ESPRESPERION THERAPEUTICS INC NEW | 7,800 | $514.0M | 0.05% | |
| 124 | —MELINTA THERAPEUTICS INC | 32,100 | $507.0M | 0.05% | |
| 125 | —ENDO INTL PLC | 63,200 | $490.0M | 0.05% | |
| 126 | —MEDICINES CO | 17,850 | $488.0M | 0.05% | |
| 127 | —ENVISION HEALTHCARE CORP | 13,026 | $450.0M | 0.05% | |
| 128 | MYGNMYRIAD GENETICS INC | 12,000 | $412.0M | 0.04% | |
| 129 | —AAC HLDGS INC | 45,000 | $405.0M | 0.04% | |
| 130 | SGRYSURGERY PARTNERS INC | 31,000 | $375.0M | 0.04% | |
| 131 | —ALDER BIOPHARMACEUTICALS INC | 30,600 | $350.0M | 0.04% | |
| 132 | ACHCACADIA HEALTHCARE COMPANY IN | 10,000 | $326.0M | 0.03% | |
| 133 | —OBALON THERAPEUTICS INC | 48,000 | $317.0M | 0.03% | |
| 134 | TBPHTHERAVANCE BIOPHARMA INC | 10,628 | $296.0M | 0.03% |
PreviousPage 2 of 2